Paola Ulivi

5.3k total citations
182 papers, 3.7k citations indexed

About

Paola Ulivi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Paola Ulivi has authored 182 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Oncology, 78 papers in Pulmonary and Respiratory Medicine and 66 papers in Cancer Research. Recurrent topics in Paola Ulivi's work include Lung Cancer Treatments and Mutations (49 papers), Colorectal Cancer Treatments and Studies (40 papers) and Cancer Genomics and Diagnostics (39 papers). Paola Ulivi is often cited by papers focused on Lung Cancer Treatments and Mutations (49 papers), Colorectal Cancer Treatments and Studies (40 papers) and Cancer Genomics and Diagnostics (39 papers). Paola Ulivi collaborates with scholars based in Italy, United States and Spain. Paola Ulivi's co-authors include Wainer Zoli, Dino Amadori, Alessandro Passardi, Matteo Canale, Giorgia Marisi, Francesco� Fabbri, Giovanni Luca Frassineti, Anna Tesei, Daniele Calistri and Rosella Silvestrini and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Paola Ulivi

172 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paola Ulivi Italy 34 1.7k 1.5k 1.4k 1.3k 484 182 3.7k
Yang Lü United States 35 1.9k 1.1× 1.9k 1.3× 906 0.7× 971 0.8× 308 0.6× 171 4.5k
Giuseppe Bronte Italy 32 1.4k 0.8× 1.1k 0.8× 866 0.6× 1.1k 0.8× 308 0.6× 106 2.9k
David R. Shalinsky United States 27 1.7k 1.0× 2.3k 1.5× 1.3k 0.9× 1.0k 0.8× 260 0.5× 52 4.3k
Susana Roselló Spain 31 2.3k 1.3× 885 0.6× 859 0.6× 1.0k 0.8× 603 1.2× 89 3.6k
E. Ramsay Camp United States 28 1.6k 0.9× 1.2k 0.8× 771 0.6× 563 0.4× 307 0.6× 65 2.8k
Hiroyuki Uetake Japan 36 2.4k 1.4× 2.1k 1.4× 1.4k 1.0× 1.0k 0.8× 899 1.9× 200 4.9k
Adrian M. Jubb United Kingdom 32 1.6k 0.9× 2.5k 1.6× 1.0k 0.7× 630 0.5× 367 0.8× 50 4.0k
Salvatore Piscuoglio Switzerland 39 1.7k 1.0× 2.5k 1.7× 2.7k 2.0× 1.0k 0.8× 861 1.8× 133 5.3k
T.R. Jeffry Evans United Kingdom 36 1.9k 1.1× 1.8k 1.2× 802 0.6× 686 0.5× 667 1.4× 107 4.4k

Countries citing papers authored by Paola Ulivi

Since Specialization
Citations

This map shows the geographic impact of Paola Ulivi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paola Ulivi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paola Ulivi more than expected).

Fields of papers citing papers by Paola Ulivi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paola Ulivi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paola Ulivi. The network helps show where Paola Ulivi may publish in the future.

Co-authorship network of co-authors of Paola Ulivi

This figure shows the co-authorship network connecting the top 25 collaborators of Paola Ulivi. A scholar is included among the top collaborators of Paola Ulivi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paola Ulivi. Paola Ulivi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maltoni, Roberta, Claudio Cerchione, Sara Bravaccini, et al.. (2025). Non-small cell lung cancer and the tumor microenvironment: making headway from targeted therapies to advanced immunotherapy. Frontiers in Immunology. 16. 1515748–1515748. 6 indexed citations
2.
Conteduca, Vincenza, Emanuela Scarpi, Alice S. Rossi, et al.. (2025). Changing metastatic patterns associate with dynamics of circulating tumor DNA in metastatic castration-resistant prostate cancer. The Oncologist. 30(5). 1 indexed citations
3.
Cortesi, Michela, Sara Bravaccini, Sara Ravaioli, et al.. (2024). HDAC6 as a Prognostic Factor and Druggable Target in HER2-Positive Breast Cancer. Cancers. 16(22). 3752–3752.
4.
5.
6.
Bertolini, Federica, Elisabetta Petracci, Stefania Bettelli, et al.. (2023). Genomic profiling in advanced NSCLC in Italy: First results of NERoNE (NSCLC Emilia Romagna Next Generation Sequencing Evaluation) project.. Journal of Clinical Oncology. 41(16_suppl). e21077–e21077.
7.
Cursano, Maria Concetta, Emilio Francesco Giunta, Emanuela Scarpi, et al.. (2023). Impact of Somatic DNA Repair Mutations on the Clinical Outcomes of Bone Metastases from Castration-Resistant Prostate Cancer. International Journal of Molecular Sciences. 24(15). 12436–12436. 3 indexed citations
8.
Passardi, Alessandro, Alessandro Bittoni, Giorgia Marisi, et al.. (2023). Inflammatory indices as prognostic markers in metastatic colorectal cancer patients treated with chemotherapy plus Bevacizumab. Therapeutic Advances in Medical Oncology. 15. 2656920–2656920. 10 indexed citations
9.
Tedaldi, Gianluca, Chiara Molinari, Ana André, et al.. (2021). Genetic and Epigenetic Alterations of CDH1 Regulatory Regions in Hereditary and Sporadic Gastric Cancer. Pharmaceuticals. 14(5). 457–457. 11 indexed citations
10.
Passardi, Alessandro, Emanuela Scarpi, & Paola Ulivi. (2021). Special Issue on Molecular and Translational Research on Colorectal Cancer 2.0. International Journal of Molecular Sciences. 22(14). 7479–7479. 1 indexed citations
11.
Urbini, Milena, Giuseppe Schepisi, Caterina Gianni, et al.. (2021). Primary Mediastinal and Testicular Germ Cell Tumors in Adolescents and Adults: A Comparison of Genomic Alterations and Clinical Implications. Cancers. 13(20). 5223–5223. 10 indexed citations
12.
Casadei‐Gardini, Andrea, Laura Del Coco, Giorgia Marisi, et al.. (2020). 1H-NMR Based Serum Metabolomics Highlights Different Specific Biomarkers between Early and Advanced Hepatocellular Carcinoma Stages. Cancers. 12(1). 241–241. 43 indexed citations
13.
Passardi, Alessandro, Emanuela Scarpi, & Paola Ulivi. (2020). Molecular and Translational Research on Colorectal Cancer. International Journal of Molecular Sciences. 21(11). 4105–4105. 4 indexed citations
14.
Ulivi, Paola, Matteo Canale, Alessandro Passardi, et al.. (2018). Circulating Plasma Levels of miR-20b, miR-29b and miR-155 as Predictors of Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer. International Journal of Molecular Sciences. 19(1). 307–307. 62 indexed citations
15.
Molinari, Chiara, Giorgia Marisi, Alessandro Passardi, et al.. (2018). Heterogeneity in Colorectal Cancer: A Challenge for Personalized Medicine?. International Journal of Molecular Sciences. 19(12). 3733–3733. 154 indexed citations
16.
Ulivi, Paola, Emanuela Scarpi, Elisa Chiadini, et al.. (2017). Right- vs. Left-Sided Metastatic Colorectal Cancer: Differences in Tumor Biology and Bevacizumab Efficacy. International Journal of Molecular Sciences. 18(6). 1240–1240. 39 indexed citations
17.
Canale, Matteo, Elisabetta Petracci, Angelo Delmonte, et al.. (2016). Impact of TP53 Mutations on Outcome in EGFR -Mutated Patients Treated with First-Line Tyrosine Kinase Inhibitors. Clinical Cancer Research. 23(9). 2195–2202. 196 indexed citations
18.
Passardi, Alessandro, Emanuela Scarpi, Stefano Tamberi, et al.. (2015). Impact of Pre-Treatment Lactate Dehydrogenase Levels on Prognosis and Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer. PLoS ONE. 10(8). e0134732–e0134732. 35 indexed citations
19.
Terragni, Rossella, Andrea Casadei‐Gardini, Silvia Sabattini, et al.. (2014). EGFR, HER-2 and KRAS in Canine Gastric Epithelial Tumors: A Potential Human Model?. PLoS ONE. 9(1). e85388–e85388. 35 indexed citations
20.
Fabbri, Francesco�, Giovanni Brigliadori, Silvia Carloni, et al.. (2008). Zoledronic acid increases docetaxel cytotoxicity through pMEK and Mcl-1 inhibition in a hormone-sensitive prostate carcinoma cell line. Journal of Translational Medicine. 6(1). 43–43. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yang Lü Breakdown of academic impact, for papers by Giuseppe Bronte Breakdown of academic impact, for papers by David R. Shalinsky Breakdown of academic impact, for papers by Susana Roselló Breakdown of academic impact, for papers by E. Ramsay Camp Breakdown of academic impact, for papers by Hiroyuki Uetake Breakdown of academic impact, for papers by Adrian M. Jubb Breakdown of academic impact, for papers by Salvatore Piscuoglio Breakdown of academic impact, for papers by T.R. Jeffry Evans
Rankless by CCL
2026